Stage 1 provides seed funding for new and established partnerships to conduct research that deepens understanding of the problem and sets the stage for testing solutions.
Seed grants from $10,000 to $150,000, for up to two years, for interdisciplinary research projects that seek to promote new understanding of ocean processes and marine life, and to inform solutions for ocean health and sustainability.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
SCI’s mission is to translate Stanford discoveries into individualized cancer care and prevention. In keeping with its goal of educating and empowering the next generation of cancer researchers, SCI offers funding to cancer research fellows.
The Innovative Medicines Accelerator seeks to accelerate the prototyping of innovative early-stage translational stem cell and gene therapies that address unmet clinical needs.
The WHSDM Center aims to promote health research on biological sex differences, women’s health, and sexual and gender minority health at the School of Medicine, and to foster collaborations on these topics across SoM depts and the University.
The Stanford MCHRI Uytengsu-Hamilton 22q11 Neuropsychiatry Research Awards Program aims to promote innovative, transdisciplinary research to improve the neurocognitive outcomes and behavioral symptoms of 22q11.2 Deletion Syndrome.
DUE: October 24th The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
The Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact is offering a Fall 2022 Seed Grant to support researchers and scientists in advancing specific domains of maternal-fetal science.